Baxter International Inc at Raymond James Institutional Investors Conference Transcript
[Audio Gap] conference. My name is Jayson Bedford. I cover medical devices here. It's really our privilege to have with us the senior management team from Baxter. We have the company's CFO, Jay Saccaro; and VP of Investor Relations, Clare Trachtman. So with that, I'm going to hand it over to Jay and he'll give a brief intro on what Baxter is more relevant today and how it benefits society and then we'll jump into some Q&A.
Great. Thank you. And it's really nice to see all of you in person. I think for the first time in a couple of years, in fact, the last presentation that I really gave in this environment was 2 years ago, at this conference, which is quite remarkable. So if I'm off my game a little bit, I apologize. No in-person presentations in the last couple of years.
But it's interesting for me because I think the last 2 years has really highlighted a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |